Prediagnostic serum selenium in a case-control study of thyroid cancer

International Journal of Epidemiology

Volumn 18, Issue 1, 1989, Pages 45-49

  Glattre, E ^a   Thomassen, Y ^b   Thoresen, S Ø ^a   Haldorsen, T ^a   Lund larsen, P G ^c   Theodorsen, L ^c   Aaseth, J ^d,e  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Institute of Clinical Biochemistry   (Norway)

^e Regional Hospital of Tromso   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM;

AGE; CASE REPORT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; THYROID CANCER;

ADENOCARCINOMA; CARCINOMA; CARCINOMA, PAPILLARY; COPPER; EPIDEMIOLOGIC METHODS; FEMALE; HUMAN; MALE; MIDDLE AGE; NORWAY; SELENIUM; SEX FACTORS; SPECTROPHOTOMETRY, ATOMIC ABSORPTION; SUPPORT, NON-U.S. GOV'T; THYROID NEOPLASMS;

EID: 0024536282     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/18.1.45     Document Type: Article

References (19)

1. Willett W C, Polk B F, Morris J S, Stampfer M J, Pressel S, Rosner B, et al. Prediagnostic selenium and risk of cancer Lancet 1983; 2: 130-4.
2. Salonen J T, Alfthan G, Huttunen J K, Puska P. Association between serum selenium and the risk of cancer. Amer J Epidemiol 1984; 120: 342-9.
3. Salonen J T, Salonen R, Lappetelainen R, et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: Matched case-control analysis of prospective data, Br Med J 1985; 290: 417-20.
4. Kok F J, De Bruijn A M, Hofman A, Vermeeren R, Valkenburg H A. Is serum selenium a risk factor for cancer in men only? Amer J Epidemiol 1987; 125: 12-6.
5. Robinson M F, Godfrey P J, Thomson C D, Rea H M, van Rij A M. Blood selenium and glutatione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand. Am J Clin Nutr 1979; 32: 1477-85.
6. Virtamo J, Valkeila E, Alfthan G, Punsar S, Huttunen J K, Karvonen M J. Serum Selenium and Risk of Cancer. A prospective Follow-Up of Nine Years. Cancer 1987; 60: 145-8.
7. Thoresen S Ø, Myking O, Glattre E, Rootwelt K, Andersen A, Foss O P. Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer. Br J Cancer 1988; 57: 105-8.
8. Jellum E, Andersen Aa, Ørjaseter H, Foss O P, Lund-Larsen P, Theodorsen L. The JANUS serum bank and early detection of cancer. Biochem Clin 1987; 11: 191-5.
9. Histological typing of thyroid tumors. WHO, Geneva, 1982.
10. Solvoll K. Comparison of dietary data from self-administered questionnaire and 24 hour recall. Oslo: Landsforeningen for kosthold og helse, 1983.
11. Saeed K, Thomassen Y, Langmyhr F J. Direct electrothermal atomic absorption spectrometric determinatin of selenium in serum. Anal Chim Acta 1979; 10: 930.
12. Dinat M, Wolynetz M S, Thomassen Y, Verlinder M. Interlaboratory trial on the determination of total selenium in lyophilized human blood serum. Pure Appl Chem 1986; 58: 1063-76.
13. Ihnat M, Thomassen Y, Wolynetz M S, Veillon C. Trace element data reliability in clinical chemistry — interlaboratory trials and reference materials. Acta Pharmacol Toxicol 1986; 59 suppl VII: 566-72.
14. Breslow N E, Day N E. Statistical methods in cancer research. Vol 1. Lyon: IARC, 1980.
15. Cancer Registry of Norway. Occurrence of cancer in Norwegian municipalities 1975-84. Oslo: Cancer Registry of Norway, 1986.
16. Ringstad J, Jacobsen B K, Tretli S, Thomassen Y. Serum selenium concentration associated with risk of cancer. J Clin Pathol 1988; 41: 954-7.
17. Central Bureau of Statistics (Opdahl, S.). Tables: Food and beverages per person per year by groups of municipalities in Norway 1977-79, 1980-82, 1983-85.
18. Aaseth I, et al. Selenium levels in the thyroid gland. Manuscript 1987.
19. Ip C. Selenium and experimental cancer. Ann Clin Res 1986; 18:22-9.